- Home
- DRIO vs BEAT Comparison
DRIO vs BEAT Comparison
Compare DRIO & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRIO | BEAT |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | United States |
| Employees | N/A | 16 |
| Industry | Medical/Dental Instruments | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.8M | 54.2M |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | DRIO | BEAT |
|---|---|---|
| Price | $8.42 | $1.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $60.00 | $6.75 |
| AVG Volume (30 Days) | 7.7K | ★ 829.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 9.05 | N/A |
| Revenue | ★ $7,394,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.15 | $288.71 |
| P/E Ratio | $0.99 | ★ N/A |
| Revenue Growth | ★ 43.02 | N/A |
| 52 Week Low | $0.38 | $0.54 |
| 52 Week High | $17.74 | $4.00 |
Technical Indicators
Market Signals| Indicator | DRIO | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 34.60 | 39.44 |
| Support Level | $0.56 | $1.17 |
| Resistance Level | $12.36 | $1.35 |
| Average True Range (ATR) | 0.62 | 0.12 |
| MACD | -0.16 | 0.00 |
| Stochastic Oscillator | 18.74 | 4.82 |
Price Performance
Historical ComparisonAbout DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.